• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Pranoprofen

Pranoprofen

Product ID P6802
Cas No. 52549-17-4
Purity ≥98%
Product Unit SizeCostQuantityStock
100 mg $102.00 In stock
250 mg $183.60 In stock
1 g $459.60 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Pranoprofen is a non-steroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory activity; it is clinically used to treat dry eye. Pranoprofen inhibits COX-1 and COX-2. Pranoprofen inhibits production of sodium urate-induced superoxide, prostaglandin E2 (PGE2), and β-glucuronidase.

Product Info

Cas No.

52549-17-4

Purity

≥98%

Formula

C15H13NO3

Formula Wt.

255.27

Chemical Name

α-Methyl-5H-[1]benzopyranol[2,3-b]pyridine-7-acetic acid

IUPAC Name

2-(5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid

Synonym

Y-8004, Niflan

Melting Point

182-183°C

Appearance

White or Light yellow crystalline powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

P6802 MSDS PDF

Info Sheet

P6802 Info Sheet PDF

References

Chen J, Dong F, Chen W, et al. Clinical efficacy of 0.1% pranoprofen in treatment of dry eye patients: a multicenter, randomized, controlled clinical trial. Chin Med J (Engl). 2014 Jul;127(13):2407-12. PMID: 24985574.

Aratani H, Iwahisa Y, Imayoshi T, et al. Mechanism of the inhibitory effect of pranoprofen on sodium urate crystal-induced inflammation. Nihon Yakurigaku Zasshi. 1987 Mar;89(3):139-44. PMID: 3556352.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T5610

    γ-Tocotrienol

    Antioxidant, vitamin E derivative found in vege...

    ≥98%
  • C9882

    Cytochalasin E

    Mycotoxin produced by Aspergillus; actin polyme...

    ≥98%
  • D5607

    Dobutamine Hydrochloride

    β1-adrenergic agonist, β2- and α1-adrenergic...

    ≥98%
  • C2468

    β-Calcitonin Gene Related Peptide, human

    Endogenous calcitonin-family peptide, involved ...

    ≥98%
  • M9644

    Myelin Basic Protein (87-99), guinea pig/human

    Immunodominant peptide epitope occurring in mul...

    ≥95%
  • T564098

    Tocored

    Tocopherol analog

  • S1810

    Secnidazole

    Nitroimidazole, binds DNA; nucleic acid synthes...

    ≥98%
  • P7082

    Prulifloxacin

    Fluoroquinolone; topoisomerase IV and bacterial...

    ≥98%
  • B1853

    1,4-Benzoquinone

    Precursor in the synthesis of hydroquinone, ant...

    ≥98%
  • T1853

    Tenovin-6

    SIRT1/2 inhibitor, indirect p53 activator.

    ≥98%
  • R5212

    RN-486

    Btk inhibitor.

    ≥98%
  • T3324

    Tigecycline

    Glycylcycline; protein synthesis inhibitor.

    ≥98%
  • C0172

    Carbimazole

    Methimazole prodrug; thyroid peroxidase inhibit...

    ≥98%
  • T5871

    Torin 2

    Tricyclic benzonaphthyridinone; mTORC1/2 inhibi...

    ≥98%
  • B0108

    Bactenecin

    Cathelicidin derivative, antimicrobial peptide,...

    ≥95%
  • B4974

    BMS-777607

    MET and Ron inhibitor.

    ≥99%
  • N8760

    NVP-TAE684

    ALK, c-Fes, LRRK2 inhibitor.

    ≥98%
  • D3351

    4-Dimethylaminopyridine

    Acyl transfer catalyst, involved in peptide syn...

    ≥98%
  • C084099

    CCCP

    Efflux pump inhibitor

    ≥99%
  • G7440

    GSK-1120212

    MEK1/2 inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only